Article
The tenocyte phenotype of human primary tendon cells in vitro is reduced by glucocorticoids.
BMC musculoskeletal disorders - 10 Nov 2016
Spang Christoph, Chen Jialin, Backman Ludvig J
Abstract excerpt
BACKGROUND: The use of corticosteroids (e.g., dexamethasone) as treatment for tendinopathy has recently been questioned as higher risks for ruptures have been observed clinically. In vitro studies have reported that dexamethasone exposed tendon cells, tenocytes, show reduced cell viability and collagen production. Little is known about the effect of dexamethasone on the characteristics of tenocytes. Furthermore,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
